Target to Scale-Up Chemistry
We integrate rigorous synthetic route design with active biological assays, delivering the analytical certainty required to advance your candidate from initial target to clinical scale.
Your Scientists Next Door
Our team operates as a direct extension of your bench. We share raw ELN data in real time, ensuring complete alignment on synthetic pathways and assay validation.
Real-Time ELN Access
Monitor reaction progress, analytical chromatograms, and raw data feeds directly through our secure project portal, ensuring complete transparency.
Synthetic Route Design
Our chemists design scalable, robust routes early in the discovery phase, minimizing downstream transfer friction and accelerating clinical timelines.
Target ID to Lead Optimisation
A structured, milestone-driven transition protocol ensures candidates are rigorously validated at every phase of the drug discovery lifecycle.
01 / Target & Hit ID
02 / Lead Optimisation
03 / Scale-Up & Transfer
We deploy high-throughput screening and custom assay development to isolate active chemical series with validated therapeutic potential.
We combine iterative medicinal chemistry with in vitro DMPK profiling to optimize candidate potency, selectivity, and safety margins.
Our process chemists optimize synthetic routes to transition your lead candidate safely and efficiently into clinical development phases.
Accelerate Your Pipeline
Discuss your target profiles and synthetic challenges with our scientific team. We provide detailed proposals within 24 hours.